Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cannvas MedTech was a Canadian health-technology company that specialized in providing data-driven educational platforms for the cannabis and healthcare industries. The company's core offering was Cannvas.me, a digital resource designed to provide consumers with evidence-based information regarding the medicinal and wellness applications of cannabis. By employing machine learning and artificial intelligence, Cannvas MedTech analyzed consumer behavior to provide actionable insights for the global cannabis market. The company was publicly traded on the Canadian Securities Exchange under the symbol MTEC. In 2021, the entity rebranded as Love Pharma Inc., pivoting its business model toward the pharmaceutical development of sexual health and psychedelic-based treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cannvas MedTech.